시장보고서
상품코드
1270474

세계의 흡입 항생제 시장 보고서(2023년)

Inhaled Antibiotics Global Market Report 2023

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 흡입 항생제 시장은 2022년 13억 4,000만 달러에서 2023년에는 14억 5,000만 달러로, CAGR 7.9%로 성장할 것으로 예측됩니다. 러시아·우크라이나 전쟁은 적어도 단기적으로는 COVID-19 팬데믹으로부터의 세계 경제 회복 가능성을 혼란시켰습니다. 이 양국 간의 전쟁은 다수의 국가에 대한 경제 제재, 상품 가격 급등, 공급망 혼란으로 이어지고, 상품이나 서비스 전체에 인플레이션을 유발하여 세계의 많은 시장에 영향을 미치고 있습니다. 흡입 항생제 시장은 2027년에는 CAGR 7.2%로 19억 2,000만 달러로 성장할 것으로 예상됩니다.

2022년 흡입 항생제 시장에서는 북미가 최대 지역이 되었습니다. 흡입 항생제 보고서 대상 지역은 아시아태평양, 서유럽, 동유럽, 북미, 남미, 중동 및 아프리카입니다.

호흡기 질환의 발생률 증가는 향후 흡입 항생제 시장의 성장을 촉진할 것으로 예상됩니다. 호흡기 질환은 폐와 기도에 손상을 입혀 사람의 호흡을 방해하는 질환입니다. 흡입 항생제는 낭포성 섬유증 환자의 폐 기능을 향상시키고 폐 기능 저하를 예방하고 악화 기간을 연장하며 삶의 질을 향상시킬 수 있습니다. 예를 들어, 2021년 11월 미국 정부 기관인 노동통계국이 발표한 통계에 따르면 2020년 고용주가 보고한 호흡기 질환 발생 건수는 42만 8700건으로 2019년 1만 800건에서 증가했습니다. 또한 풀타임 근로자 10,000명당 호흡기 질환 발생 건수는 2019년 1.1건에서 2020년 44.0건으로 증가했습니다. 따라서 호흡기 질환 발생 건수의 증가가 흡입 항생제 시장을 주도하고 있습니다.

목차

제1장 주요 요약

제2장 흡입 항생제 시장 특징

제3장 흡입 항생제 시장 동향과 전략

제4장 흡입 항생제 시장 - 거시경제 시나리오

  • COVID-19가 흡입 항생제 시장에 미치는 영향
  • 우크라이나·러시아 전쟁이 흡입 항생제 시장에 미치는 영향
  • 고인플레이션이 흡입 항생제 시장에 미치는 영향

제5장 흡입 항생제 시장 규모와 성장

  • 세계의 흡입 항생제 시장 실적, 2017-2022년
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
  • 세계의 흡입 항생제 시장 예측, 2022-2027F, 2032F
    • 시장 성장 촉진요인
    • 시장 성장 억제요인

제6장 흡입 항생제 시장 세분화

  • 세계의 흡입 항생제 시장, 제품 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 에어로졸 또는 정량 흡입기
  • 드라이 파우더 제제
  • 분사
  • 기타 유형
  • 세계의 흡입 항생제 시장, 용도별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 폐렴
  • 천식
  • 기관지염
  • 기타 용도
  • 세계의 흡입 항생제 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 병원
  • 기타 최종사용자

제7장 흡입 항생제 시장 지역 및 국가 분석

  • 세계의 흡입 항생제 시장, 지역별, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 세계의 흡입 항생제 시장, 국가별, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제8장 아시아태평양의 흡입 항생제 시장

  • 아시아태평양의 흡입 항생제 시장 개요
  • 지역 정보, COVID-19증의 영향, 시장 정보, 배경 정보, 정부 대처, 규제, 규제기관, 주요 단체, 과세액, 법인세 구조, 투자, 주요 기업
  • 아시아태평양의 흡입 항생제 시장, 제품 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 아시아태평양의 흡입 항생제 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제9장 중국의 흡입 항생제 시장

  • 중국의 흡입 항생제 시장 개요
  • 중국 흡입 항생제 시장, 제품 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 중국 흡입 항생제 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제10장 인도의 흡입 항생제 시장

  • 인도 흡입 항생제 시장, 제품 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 인도 흡입 항생제 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제11장 일본의 흡입 항생제 시장

  • 일본의 흡입 항생제 시장, 제품 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 일본의 흡입 항생제 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제12장 호주의 흡입 항생제 시장

  • 호주 흡입 항생제 시장, 제품 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 호주 흡입 항생제 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제13장 인도네시아의 흡입 항생제 시장

  • 인도네시아 흡입 항생제 시장, 제품 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 인도네시아 흡입 항생제 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제14장 한국의 흡입 항생제 시장

  • 한국의 흡입 항생제 시장, 제품 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 한국의 흡입 항생제 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제15장 서유럽의 흡입 항생제 시장

  • 서유럽의 흡입 항생제 시장 개요
  • 서유럽의 흡입 항생제 시장, 제품 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 서유럽의 흡입 항생제 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제16장 영국의 흡입 항생제 시장

  • 영국 흡입 항생제 시장, 제품 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 영국 흡입 항생제 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제17장 독일의 흡입 항생제 시장

  • 독일 흡입 항생제 시장, 제품 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 독일 흡입 항생제 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제18장 프랑스의 흡입 항생제 시장

  • 프랑스 흡입 항생제 시장, 제품 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 프랑스 흡입 항생제 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제19장 동유럽의 흡입 항생제 시장

  • 동유럽의 흡입 항생제 시장 개요
  • 동유럽의 흡입 항생제 시장, 제품 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 동유럽의 흡입 항생제 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제20장 러시아의 흡입 항생제 시장

  • 러시아 흡입 항생제 시장, 제품 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 러시아 흡입 항생제 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제21장 북미의 흡입 항생제 시장

  • 북미의 흡입 항생제 시장 개요
  • 북미 흡입 항생제 시장, 제품 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 북미 흡입 항생제 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제22장 미국의 흡입 항생제 시장

  • 미국의 흡입 항생제 시장 개요
  • 미국 흡입 항생제 시장, 제품 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 미국 흡입 항생제 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제23장 남미의 흡입 항생제 시장

  • 남미 흡입 항생제 시장 개요
  • 남미 흡입 항생제 시장, 제품 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 남미 흡입 항생제 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제24장 브라질의 흡입 항생제 시장

  • 브라질 흡입 항생제 시장, 제품 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 브라질 흡입 항생제 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제25장 중동의 흡입 항생제 시장

  • 중동의 흡입 항생제 시장 개요
  • 중동의 흡입 항생제 시장, 제품 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 중동의 흡입 항생제 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제26장 아프리카의 흡입 항생제 시장

  • 아프리카의 흡입 항생제 시장 개요
  • 아프리카 흡입 항생제 시장, 제품 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 아프리카 흡입 항생제 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제27장 흡입 항생제 시장 경쟁 상황과 기업 개요

  • 흡입 항생제 시장 경쟁 상황
  • 흡입 항생제 시장 기업 개요
    • Gilead Sciences Inc
    • Lupin Limited
    • Insmed, Inc
    • Savara Inc
    • Joincare Pharmaceutical Group Industry Co., Ltd.

제28장 흡입 항생제 시장의 주요 인수합병

제29장 흡입 항생제 시장 향후 전망과 가능성 분석

제30장 부록

KSM 23.05.19

“Inhaled Antibiotics Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on inhaled antibiotics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for inhaled antibiotics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The inhaled antibiotics market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product Type: Aerosol or Metered Dose Inhaler; Dry Powder Formulation; Spray; Other Types
  • 2) By Application: Pneumonia; Asthma; Bronchitis; Other Applications
  • 3) By End-User: Hospitals; Other End Users
  • Companies Mentioned: Gilead Sciences Inc; Lupin Limited; Insmed, Inc; Savara Inc; Joincare Pharmaceutical Group Industry Co., Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the inhaled antibiotics market are Gilead Sciences Inc., Lupin Limited, Insmed, Inc., Savara Inc., Joincare Pharmaceutical Group Industry Co., Ltd., Pharmaxis Ltd., Teva Pharmaceutical Industries Ltd., Raptor Pharmaceutical Corporation, Altan Pharma Limited, Cipla Limited, Maya Biotech Pvt. Ltd., Medisol Lifescience Pvt. Ltd., Nivon Specialties, Sentiss Pharma Pvt. Ltd., Ultratech India Limited, Midas Care Pharmaceuticals Pvt Ltd., Precept Pharma Ltd., and Luckys Pharma.

The global inhaled antibiotics market is expected to grow from $1.34 billion in 2022 to $1.45 billion in 2023 at a compound annual growth rate (CAGR) of 7.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The inhaled antibiotics market is expected to grow to $1.92 billion in 2027 at a CAGR of 7.2%.

The inhaled antibiotics market consists of sales of jet nebulizers, ultrasonic nebulizers, mesh inhalers, and soft mist inhalers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Inhaled antibiotics refer to drugs that act as medication for respiratory-related problems. Inhaled antibiotics have enhanced survival and have been used to improve lung function, delay deterioration in lung function, extend time between exacerbations, and improve quality of life.

North America was the largest region in the inhaled antibiotics market in 2022. The regions covered in the inhaled antibiotics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main types of inhaled antibiotics are aerosol or metered dose inhalers, dry powder formulations, sprays and others. A metered-dose inhaler, or MDI, is a device that is frequently used to provide inhaled respiratory drugs. These are used in various applications such as pneumonia, asthma, bronchitis and others, which are used by hospitals, and others.

The increasing incidence of respiratory diseases is expected to propel the growth of the inhaled antibiotics market going forward. Respiratory disease is a disease that damages the lungs and airways and impairs breathing in people. Inhaled antibiotics enhance lung function, prevent lung function decline, extend the period between exacerbations, and enhance the quality of life in cystic fibrosis patients. For instance, in November 2021, according to stats published by the US bureau of labor statistics, a US-based government agency, there was an increase in employer-reported respiratory illness cases in 2020 at 428,700, up from 10,800 in 2019. The number of incidents of respiratory illness per 10,000 full-time equivalent workers increased from 1.1 in 2019 to 44.0 in 2020. Therefore, an increasing incidence of respiratory diseases drives the inhaled antibiotics market.

Investments in the development of inhaled antibiotics are a key trend gaining popularity in inhaled antibiotics market. Major pharmaceutical companies are investing in the development of inhaled antibiotics to sustain their position in the market. For instance, in December 2021, Enbiotix, a US-based drug development company invested $11 million in the development of antibiotics for lung infections. This funding would help with clinical testing of murepavadin, and ColiFin (inhaled colistimethate sodium) that are used for patients suffering from cystic fibrosis (CF).

In August 2021, Philip Morris International Inc., a US-based Tobacco company, acquired OtiTopic for an undisclosed amount. This acquisition is part of PMI's strategic objective to expand its pipeline of inhaled therapies and respiratory medication delivery by using its expertise, scientific know-how, and inhalation capabilities apart from nicotine. OtiTopic is a US-based respiratory drug development company including inhaled antibotics.

The countries covered in the inhaled antibiotics market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The inhaled antibiotics market research report is one of a series of new reports from The Business Research Company that provides inhaled antibiotics market statistics, including inhaled antibiotics industry global market size, regional shares, competitors with an inhaled antibiotics market share, detailed inhaled antibiotics market segments, market trends and opportunities, and any further data you may need to thrive in the inhaled antibiotics industry. This inhaled antibiotics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Table of Contents

1. Executive Summary

2. Inhaled Antibiotics Market Characteristics

3. Inhaled Antibiotics Market Trends And Strategies

4. Inhaled Antibiotics Market - Macro Economic Scenario

  • 4.1. COVID-19 Impact On Inhaled Antibiotics Market
  • 4.2. Ukraine-Russia War Impact On Inhaled Antibiotics Market
  • 4.3. Impact Of High Inflation On Inhaled Antibiotics Market

5. Inhaled Antibiotics Market Size And Growth

  • 5.1. Global Inhaled Antibiotics Historic Market, 2017-2022, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Inhaled Antibiotics Forecast Market, 2022-2027F, 2032F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Inhaled Antibiotics Market Segmentation

  • 6.1. Global Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Aerosol or Metered Dose Inhaler
  • Dry Powder Formulation
  • Spray
  • Other Types
  • 6.2. Global Inhaled Antibiotics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Pneumonia
  • Asthma
  • Bronchitis
  • Other Applications
  • 6.3. Global Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Hospitals
  • Other End Users

7. Inhaled Antibiotics Market Regional And Country Analysis

  • 7.1. Global Inhaled Antibiotics Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 7.2. Global Inhaled Antibiotics Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Inhaled Antibiotics Market

  • 8.1. Asia-Pacific Inhaled Antibiotics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 8.3. Asia-Pacific Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Inhaled Antibiotics Market

  • 9.1. China Inhaled Antibiotics Market Overview
  • 9.2. China Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
  • 9.3. China Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Inhaled Antibiotics Market

  • 10.1. India Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 10.2. India Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Inhaled Antibiotics Market

  • 11.1. Japan Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 11.2. Japan Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Inhaled Antibiotics Market

  • 12.1. Australia Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 12.2. Australia Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Inhaled Antibiotics Market

  • 13.1. Indonesia Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 13.2. Indonesia Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Inhaled Antibiotics Market

  • 14.1. South Korea Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 14.2. South Korea Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Inhaled Antibiotics Market

  • 15.1. Western Europe Inhaled Antibiotics Market Overview
  • 15.2. Western Europe Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 15.3. Western Europe Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Inhaled Antibiotics Market

  • 16.1. UK Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 16.2. UK Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Inhaled Antibiotics Market

  • 17.1. Germany Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 17.2. Germany Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Inhaled Antibiotics Market

  • 18.1. France Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 18.2. France Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Inhaled Antibiotics Market

  • 19.1. Eastern Europe Inhaled Antibiotics Market Overview
  • 19.2. Eastern Europe Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 19.3. Eastern Europe Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Inhaled Antibiotics Market

  • 20.1. Russia Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 20.2. Russia Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Inhaled Antibiotics Market

  • 21.1. North America Inhaled Antibiotics Market Overview
  • 21.2. North America Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 21.3. North America Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Inhaled Antibiotics Market

  • 22.1. USA Inhaled Antibiotics Market Overview
  • 22.2. USA Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 22.3. USA Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Inhaled Antibiotics Market

  • 23.1. South America Inhaled Antibiotics Market Overview
  • 23.2. South America Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 23.3. South America Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Inhaled Antibiotics Market

  • 24.1. Brazil Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 24.2. Brazil Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Inhaled Antibiotics Market

  • 25.1. Middle East Inhaled Antibiotics Market Overview
  • 25.2. Middle East Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 25.3. Middle East Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Inhaled Antibiotics Market

  • 26.1. Africa Inhaled Antibiotics Market Overview
  • 26.2. Africa Inhaled Antibiotics Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 26.3. Africa Inhaled Antibiotics Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Inhaled Antibiotics Market Competitive Landscape And Company Profiles

  • 27.1. Inhaled Antibiotics Market Competitive Landscape
  • 27.2. Inhaled Antibiotics Market Company Profiles
    • 27.2.1. Gilead Sciences Inc
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Lupin Limited
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Insmed, Inc
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Savara Inc
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Joincare Pharmaceutical Group Industry Co., Ltd.
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Inhaled Antibiotics Market

29. Inhaled Antibiotics Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Historic And Forecast Inflation Rates
  • 30.4. Research Inquiries
  • 30.5. The Business Research Company
  • 30.6. Copyright And Disclaimer
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제